BSE filing, NSE: RAINBOW. Summary written from the filing by ALFA Finder's alert engine.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,204.80
- Market cap
- ₹12,237 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 42.9×Sector 52.0×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Rainbow Childrens Medicare Capacity Expansion
Rainbow Children’s Medicare entered a 60-year lease for 2 acres in Amaravati with APCRDA. The site will house a new 250-bed super speciality children’s hospital.
- From
- Andhra Pradesh Capital Region Development Authority (APCRDA)
- Execution
- 60 years
- hospital beds
- 250.0 beds
Rainbow Childrens Medicare Credit Rating
ICRA Limited has reaffirmed the [ICRA] AA (Stable) issuer rating for Rainbow Children's Medicare Limited. This periodic rating review confirms the company's existing credit standing.
Rainbow Childrens Medicare Management Change
Rainbow Childrens Medicare Limited has appointed Mr. Sudarshan Patodia as the Chief Financial Officer, effective September 23, 2026.
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare Limited granted 55,690 stock options to eligible employees under its ESOP 2025 scheme.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.